2Sun Y, Lu C J, Chen Rc, et al. Lack of associatiaon between total serum homocysteine and extracranial cerebral flow [J]. J Formos Med Assoc ,2010,109(4) :278-286.
4Pierdomenico SD, BucciA, LapennaD, et al. Circulating homocysteine levels in sustained and white coat hypertension [ J ]. JHum Hypertens, 2003, 17: 165.
5DariusH, Pittrow D, Haberl R, et al. Are elevated hornocysteine plasma levels related to peripheral arterialdisease? Results from a cross - sectional study of 6880 primary care patients [ J]. Eur J Clin Invest, 2003, 33: 751.
6AronowWS. Homocysteine. The association with atherosclerotic vascular disease in elder persons [J]. Geriatrics, 2003, 58: 22.
7Eriksson P, Deguch H, samnegard A, et al. Humane evidence that zhe Cystatin C geneisimplicate in focal progression of coronary aftery disease [J]. Arteriosele Thromb Vase Biol, 2004, 24:551-557.
8Upchurch GR Jr, WelchGN, FabianAJ, et al Homocysteine decreases bioavailable nitric oxide by amechanism involving glutathione peroxidase [J]. J Biol ehem, 1997, 272: 17012.
9Stander JS, Osborne JA, JarakiO, et al. Adverse vascular effect of homocysteine aremodulated by endothelium - derived relaxing factor and relareal oxides ofnitrogen [J]. J Clin Invest, 1993, 91 : 308.
10Eikelboom JW, HankeyGJ, Anand SS, eta. 1 Association between high homocysteine and ischemic stroke due to large - and small - artery disease but not other etiological subtypes of ischemic stroke [ J ]. Stroke, 2000, 31: 1069.
3Antonello Ganau, Devereux, Richard B, Roman, Mary J, De Simo- ne, Giovanni, Pickering, Thomas G, Saba, Pier Sergio, Vargiu, Pa- olo, Simongini, Isabella, Laragh, Fohn H. Patterns of left ventrieular hypertrophy and geometric remodeling in essential hypertension [ J ]. J Amer Coll Cardiol, 1992,19 (7) : 1550-1558.
4Jacques Blaeher, Demuth, Karine, Guerin, Alain P, Vadez, Chan- tal, Moatti, Nieole, Safar, Michel E, London, G6rard M. Association between plasma homoeysteine concentrations and cardiac hypertro- phy in end-stage renal disease [J]. J Nephrol, 1999,12 (4) :248.
5Uv Kharlamova, Ilyieheva, Oe. Effect of homoeysteine on left ven- trieular structural and functional parameters in patients on pro- grammed hemodialysis [ J ]. TERAPEVTICHESKII ARKHIV, 2013,85 (3) :90-93.
6Johan Sundstrom, Sullivan, Lisa, Selhub, Jacob, Benjamin, EmeliaJ, D'agostirto, Ralph B, Jacques, Paul F, Roseberg, h'win H, Levy, Daniel, Wilson, Peter Wf, Vasan, Ramachandran S. Relations of plasma homocysteine to left ventricular structure and tunction : the Framingham Heart Study [ J ]. Europ Heart J, 2004,25 ( 6 ) : 523- 530.
7Richard B Devereux, Alonso, Daniel R, Latas, Elizabeth M, Gotfli- eb, Geoffrey J, Campo, Emilio, Sachs, Irene, Reichek, Nathaniel. Echocardiographic assessment of left ventricular hypertrophy:com- parison to necropsy findings [ J ]. Amer J Cardiol, 1986,57 ( 6 ) : 450-458.
8Homocysteine Studies Collaboration chemic heart disease and stroke[ J] . Homocysteine and risk of is- JAMA,2002,288(16) :2015-2022.
9Naveed S lqbal, Wu, Yuping, Hazen, Stanley, Tang, Wh. Elevated Plasma Homocysteine Identifies Patients With Chronic Heart Fail- ure at Increased Cardiovascular Risk[J]. J Card Fail, 2012, 19(8) :S87.
10Ian Mcdonald, Connolly, Maureen, Tobin, Anne-Marie. A review of psoriasis, a known risk factor for cardiovascular disease and its im- pact on folate and homocysteine metabolism[J]. J Nutrit Metabol, 2012,2012.
